Overview

Kody Technolab Limited (NSE: KODYTECH), a deep‑tech robotics and AI firm, announced a multi‑year, three‑year tripartite agreement with Falcon Tech Robotics LLC, a UAE‑based joint venture, and Sccore AI Tech Diagnostic Limited, also based in the UAE. Under the agreement, Kody Technolab is appointed the exclusive worldwide manufacturer of its Medigo range of AI‑powered healthcare screening robots. Falcon Tech Robotics will serve as the exclusive global distributor, while Sccore AI Tech Diagnostic will be responsible for worldwide deployment and commercialization of the products.

Commercial Structure

The agreement includes a binding minimum purchase framework that is structured across bi‑annual commercial periods, giving Kody Technolab structured commercial visibility throughout the term. Manufacturing and supply of Medigo units are scheduled to commence in the first half of FY 2026‑27 and will continue for the duration of the three‑year term.

Medigo Product Portfolio

The Medigo range consists of four distinct robots:

  • Medigo Static – a stationary autonomous screening robot for fixed locations such as primary health centres, corporate campuses, and other high‑footfall sites.
  • Medigo Kids – a paediatric screening robot designed for schools, paediatric clinics, and community child‑health programmes.
  • Medigo Women – a women’s health screening robot targeting gender‑specific preventive checks covering maternal, reproductive, and general wellness parameters.
  • Medigo Mobile – a mobile “health screening ATM” robot for on‑demand, last‑mile deployments at transit hubs, rural outreach routes, and other high‑traffic public spaces.

Each unit screens for a broad spectrum of metabolic, cardiovascular, infectious, sensory and mental health conditions, generates a consolidated report within minutes in the patient’s preferred language, and feeds anonymised real‑time data into institutional and government health dashboards.

Market Context

According to WHO and World Bank estimates, roughly 4.5 billion people—over half the world’s population—lack full access to essential health services. Industry research projects the global preventive healthcare market to expand from approximately USD 268.7 billion in 2023 to USD 585.6 billion by 2030, underscoring a substantial addressable market for AI‑driven autonomous screening platforms like Medigo.

Management Commentary

Manav Subhashchandra Patel, Managing Director of Kody Technolab, described the agreement as “a defining moment” that provides an integrated route to international markets through exclusive worldwide manufacturing, global distribution via the UAE joint venture, and on‑ground deployment by Sccore. Prashant Sawant, Chairman & MD of Sccore AI Tech Diagnostic, highlighted the partnership’s potential to meet the critical unmet need for timely, affordable preventive screening worldwide.

About the Parties

  • Kody Technolab Ltd – a leading deep‑tech company developing autonomous robotics and AI solutions for commercial, retail, and industrial environments, with deployments across the Middle East and Asia.
  • Falcon Tech Robotics LLC – a UAE joint venture between Kody Technolab and Platinum Group for Businessmen Services LLC, focused on accelerating robotics adoption in the Middle East.
  • Sccore AI Tech Diagnostic Limited – a UAE‑based firm specializing in the deployment and commercialization of AI‑powered diagnostic and healthcare technology solutions across global markets.

Forward‑Looking Statements

The release contains forward‑looking statements regarding the company’s plans, execution timelines, and market estimates, which are subject to risks and uncertainties; actual results may differ materially.